Беляков Н.А., Рассохин В.В., Трофимова Т.Н., Степанова Е.В., Пантелеев А.М., Леонова О.Н., Бузунова С.А., Коновалова Н.В., Миличкина А.М., Тотолян А.А. Коморбидные и тяжелые формы ВИЧ-инфекции в России // ВИЧ-инфекция и иммуносупрессии. 2016. Т. 8, № 3. С. 9–24. [Belyakov N.A., Rassokhin V.V., Trofimova T.N., Stepanova E.V., Panteleev A.M., Leonova O.N., Buzunova S.A., Konovalova N.V., Milichkina A.M., Totolyan A.A. Comorbid and severe forms of HIV infection in Russia. HIV Infection and Immunosuppressive Disorders, 2016, Vol. 8, No. 3, pp. 9–24 (In Russ.)].

Леонова О.Н., Степанова Е.В., Беляков Н.А. Тяжелые и коморбидные состояния у больных с ВИЧ-инфекцией: анализ неблагоприятных исходов // ВИЧ-инфекция и иммуносупрессии. 2017. Т. 9, № 1. С. 55–64. [Leonova O.N., Stepanova E.V., Belyakov N.A. Severe comorbid conditions in patients with HIV infection: analysis of adverse outcomes. HIV Infection and Immunosuppressive Disorders, 2017, Vol. 9, No. 1, pp. 55–64 (In Russ.)].

Беляков Н.А., Рассохин В.В., Леонова О.Н., Степанова Е.В., Бобрешова А.С. Интегральная оценка тяжести состояния больного на фоне коморбидности при ВИЧ-инфекции // ВИЧ- инфекция и иммуносупрессии. 2017. Т. 9, № 3. С. 47–53. [Belyakov N.A., Rassokhin V.V., Leonova O.N., Stepanova E.V., Bobreshova A.S. Integral estimation of the patient’ condition severity against the background of comorbidity in HIV infection. HIV Infection and Immunosuppressive Disorders, 2017, Vol. 9, No. 3, pp. 47–53 (In Russ.)].

Нефрология: национальное руководство / Под ред. Н.А.Мухина. М.: ГЭОТАР-Медиа, 2009. 720 с. [Nephrology: national manual. Ed. N.A.Mukhina. Moscow: GEOTAR-Media, 2009, 720 p.(In Russ.)].

URL: https://spid-vich-zppp.ru/statistika/ofitsialnaya-statistika-vich-spid-rf-2016.html.https://spid-vich-zppp.ru/statistika/ofitsialnaya-statistika-vich-spid-rf-2016.html

Infectious Disease and Nephrology Region Medscape. 2015, NephMadness.

Kimmel P.L., Barisoni L., Kopp J.B. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann. Intern. Med., 2003, No. 139, pp. 214–226 [PubMed].

Ющук Н.Д., Волгина Г.В., Томилина Н.А., Гаджикулиева М.М., Кочарян К.А. Нефротоксические эффекты высокоактивной антиретровирусной терапии (Обзор литературы) // Нефрология и диализ. 2010. Т. 12, № 3. С. 154–163. [Yushchuk N.D., Volgina G.V., Tomilina N.A. Gadzhikulieva M.M., Kocharyan K.A. Nephrotoxic effects of highly active antiretroviral therapy (Literature Review). Nephrology and Dialysis, 2010, Vol. 12, No. 3, pp. 154–163 (In Russ.)].

Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, and Charles E. Alpers, MD. Eds. AJKD. Atlas of Renal Pathology: HIV-Associated Immune Complex Kidney Disease (HIVICK).

Национальные клинические рекомендации «Хроническая болезнь почек у ВИЧ-инфицированных пациентов (причины, диагностика, принципы ведения)» / Г.В.Волгина, M.M.Гаджикулиева. M., 2015. [National clinical guidelines «Chronic kidney disease in HIV-infected patients (causes, diagnosis, principles of management)». Eds. G.V.Volgina, M.M.Gadzhikulieva. Moscow, 2015 (In Russ.)].

HIV-1 and Kidney Cells: Better Understanding of Viral Interaction. Joanna Mikulak and Pravin C.; Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. Ed. E.T.Overton et al. HIV Med., 2009, Vol. 10, pp. 343–350.

Abraham A.G., Althoff K.N., Jing Y., Estrella M.M., Kitahata M.M., Wester C.W., Bosch R.J., Crane H., Eron J., Gill M.J., Horberg M.A., Justice A.C., Klein M., Mayor A.M., Moore R.D., Palella F.J., Parikh C.R., Silverberg M.J., Golub E.T., Jacobson L.P., Napravnik S., and Lucas G.M. End-Stage Renal Disease Among HIV-Infected Adults in North America. Clinical Infectious Diseases, 2015, Vol. 60 (6), pp. 941– 949.

Bruggeman L.A., Bark С., Kalayjian R.C. HIV and the Kidney. Curr. Infect. Dis. Rep., 2009, Vol. 11 (6), pp. 479–485.

Laurinavicius A., Rennke H.G. Collapsing glomerulopathy — a new pattern of renal injury. Semin. Diagn. Pathol., 2002, Vol. 19 (3), pp. 106–115.

Kopp J.B., Smith M.W., Nelson G.W., Johnson R.C., Freedman B.I., Bowden D.W., Oleksyk T., McKenzie L.M., Kajiyama H., Ahuja T.S., Berns J.S., Briggs W., Cho M.E., Dart R.A., Kimmel P.L., Korbet S.M., Michel D.M., Mokrzycki M.H., Schelling J.R., Simon E., Trachtman H., Vlahov D., Winkler C.A. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet., 2008, No. 40, pp. 1175–1184.

Мухин Н.А., Фомин В.В. ВИЧ-ассоциированная нефропатия: стратегии диагностики и лечения // Клиническая нефрология. 2010. № 4. С. 69–75. [Mukhin N.A., Fomin V.V. HIV- associated nephropathy: strategies for diagnosis and treatment. Clinical Nephrology, 2010, No. 4, pp. 69–75 (In Russ.)].

Huber T.B., Reinhardt H.C., Exner M., Burger J.A., Kerjaschki D., Saleem M.A., Pavenstädt H. Expression of functional CCR and CXCR chemokine receptors in podocytes. J. Immunol., 2002, No. 168, pp. 6244–6252 [PubMed].

Haraouse J.M, Kunsch C., Hartle H.T., Laughlin M.A., Hoxie J.A., Wigdahl B., Gonzalez-Scarano F. CD4-independent infection of human neural cells by immunodeficiency virus, type 1. J. Virol, 1989, No. 63, pp. 2527–2533 [PMC free article] [PubMed].

Tokizawa S., Shimizu N., Hui-Yu L., Deyu F., Haraguchi Y., Oite T., Hoshino H. Infection of mesangial cells with HIV and SIV: identification of GPR1 as a coreceptor. Kidney Int., 2000, No. 58, pp. 607–617 [PubMed].

Lucas G.M., Ross M.J., Stock P.G. et al. Executive summary: clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin. Infect. Dis., 2014, No. 59 (9), pp. 1203–1207.

Meneses G.C., Cavalcante M.G., Da Silva Junior G., Martins A.M., Neto R.D., Liborio A., Daher E. Endothelial glycocalyx damage and renal dysfunction in HIV patients receiving combined antiretroviral therapy. AIDS Res. Hum. Retroviruses, 2017, Mar 6.

Stokes M.B., Chawla H., Brody R.I. et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am. J. Kidney Dis., 1997, No. 29, pp. 514–525.

Roe J., Campbell L.J., Ibrahim F. et al. HIV care and the incidence of acute renal failure. Clin. Infect. Dis., 2008, No. 47, pp. 242–249.

Choi A.I., Li Y., Parikh C., Volberding P.A., Shlipak M.G. Long-term clinical consequences of acute kidney injury in the HIV-infected. Kidney Int., 2010, No. 78 (5), pp. 478–485.

Li Y., Shlipak M.G., Grunfeld C., Choi A.I. Incidence and risk factors for acute kidney injury in HIV infection. Am. J. Nephrol., 2012, No. 35 (4), pp. 327–334.

Nadkarni G.N., Patel A.A., Yacoub R. et al. The burden of dialysis-requiring acute kidney injury among hospitalized adults with HIV infection: a nationwide inpatient sample analysis. AIDS, 2015, No. 29 (9), pp. 1061–1066.

Franceschini N., Napravnik S., Eron J. Jr., Szczech L.A., Finn W.F. Incidence and etiology of acute renal failure among ambulatory HIV infected patients. Kidney Int., 2005, No. 67 (4), pp. 1526–1531.

Braun D.L., Kouyos R.D., Balmer B., Grube C., Weber R., Günthard H.F. Frequency and spectrum of unexpected clinical manifestations of primary HIV-1 infection. Clin. Infect. Dis., 2015, May 19.

Клинические аспекты ВИЧ-инфекции / Дж.Бартлетт, Дж.Галлант, П.Фам. М.: Р.Валент, 2010. 490 c. [Clinical aspects of HIV infection. Eds. J.Bartlett, J.Gallant, P.Pham. Moscow: R.Valent, 2010, 490 p. (In Russ.)].

Wyatt C.M. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS, 2006, Vol. 20 (4), pp. 561–565.

Беляков Н.А., Багненко С.Ф., Дубикайтис П.А., Алимов Р.Р., Виноградова Т.Н. Результаты десятилетнего выявления ВИЧ-инфекции в стационаре скорой медицинской помощи // Медицинский академический журнал. 2014. Т. 14, № 2. С. 48–54. [Belyakov N.A., Bagnenko S.F., Dubikaitis P.A., Alimov R.R., Vinogradova T.N. The results of a decade of HIV-infection in the hospital medical emergency. Medical Academic Journal, 2014, Vol. 14, No. 2, pp. 48–54 (In russ.)].

Багненко С.Ф., Дубикайтис П.А., Минаева Н.В., Рассохин В.В., Беляков Н.А. Структура обращений ВИЧ-инфицированных больных в стационар скорой помощи // ВИЧ-инфекция и иммуносупрессии. 2011. Т. 3, № 3. С. 81–87. [Bagnenko S.F., Dubikaitis P.A., Minaeva N.V., Rassokhin V.V., Belyakov N.A. The structure of treatment of HIV infected patients in an emergency hospital. HIV Infection and Immunosuppressive Disorders, 2011, Vol. 3, No. 3, pp. 81–87 (In Russ.)].

Daudon M., Estepa L., Viard J.P. et al. Urinary stones in HIV-1-positive patients treated with indinavir. Lancet, 1997, Vol. 349, pp. 1294–1295.

Colomba C., Siracusa L., Madonia S., Bonura S., Rubino R. Inreversible acute renal failure and cholestatic hepatitis following therapy with indomethacin in a HIV-naive patient with pericarditis: a case report. Infez. Med., 2014, No. 22 (3), pp. 247–249.

Lazarus Jeffrey V., Laut K.G., Safreed-Harmon K., Peters L., Johnson M., Fätkenheuer G., Khromova I., Vandekerckhove L., Maciejewska K., Radoi R., Lisa Ridolfo A., Mocroft A. Disparities in HIV clinic care across Europe: Findings from the EuroSIDA clinic survey. BMC Infectious Diseases, 2016, No. 16, pp. 335.

Karras A., Lafaurie M., Furco A. et al. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin. Infect. Dis., 2003, Vol. 36 (8), pp. 1070–1073.

Mocroft Amanda, Kirk Ole, Reiss Peter, De Wit Stephane, Sedlacek Dalibor, Beniowski Marek, Gatell Jose, Phillips Andrew N., Ledergerber Bruno, Lundgren Jens D. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS, 2010, No. 24, pp. 1667–1678.

Cirino C.M., Kan V.L. Hypokalemia in HIV patients on tenofovir. AIDS, 2006, No. 20, pp. 1671–1673.

Boffa J.J. Stenose atheromateuse de l’artere renale chez le jeune patient VIH. Nephrol. Ther., 2007, Vol. 5, pp. 303.

Нефрология. Основы диагностики / Под ред. В.П.Терентьева. Ростов-на-Дону: Феникс, 2003. [Nephrology. Bases of diagnostics. Ed. V.P.Terentyev. Rostov-on-don: Phoenix, 2003 (In Russ.)].

Национальные рекомендации по диспансерному наблюдению и лечению больных ВИЧ-инфекцией (клинический протокол). М., 2015. [National guidelines for dispensary observation and treatment of patients with HIV infection (clinical Protocol). Moscow, 2015 (In Russ.)].

Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America.

Medapalli R.K., Parikh C.R., Gordon K. et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. AIDS, 2012, No. 60 (4), pp. 393–399.

Mallipattu S.K., Liu R., Zhong Y. et al. Expression of HIV transgene aggravates kidney injury in diabetic mice. Kidney Int., 2013, No. 83 (4), pp. 626–634.

Soriano V., Rodriguez-Rosado R., Garcia-Samaniego J. Management of chronic hepatitis С in HIV-infected patients. AIDS, 1999, No. 13, pp. 539–546.

Wyatt C.M., Malvestutto C., Coca S.G., Klotman P.E., Parikh C.R. The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS, 2008, No. 22 (14), pp. 1799–1807.

Гаджикулиева М.М., Ющук Н.Д., Мартынов Ю.В., Волгина Г.В. Частота маркеров и факторы риска повреждения почек при ВИЧ-инфекции // Здоровье населения и среда обитания. 2011. № 6. С. 33–35. [Gadzhikulieva M.M., Yushchuk N.D., Martynov Yu.V., Volgina G.V. Frequency markers and risk factors of renal damage in HIV infection. Health of the Population and Habitat, 2011, No. 6, pp. 33–35 (In Russ.)].

URL: http://www.roche.ru/home/zaboljevanija/virusologija/koinfjekzija-vitch-vgs.html.http://www.roche.ru/home/zaboljevanija/virusologija/koinfjekzija-vitch-vgs.html

Haydon G.H., Flegg P.J., Blair C.S. et al. The impact of chronic hepatitis С virus infection on HIV disease and progression in intravenous drug users. Eur. J. Gastroenterol. Hepatol., 1998, No. 10 (6), pp. 485–489.

Mocroft A., Neuhaus J., Peters L. et al. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One, 2012, No. 7 (7), pp. e40245.

Peters L., Grint D., Lundgren J.D. et al. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients. AIDS, 2012, No. 26 (15), pp. 1917–1926.

Lucas G., Jing Y., Sulkowski M. et al. Hepatitis C co-infection and the risk of chronic kidney disease in HIV+ individuals: Does hepatitis C Viremia matter? [Abstract 718]. Conference on Retroviruses and Opportunistic Infections. March 3–6, 2013, Atlanta, Georgia.

Miyajima I., Kawaguchi T., Fukami A., Nagao Y., Adachi H., Sasaki S. et al. Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area. J. Gastroenterol., 2013, No. 48, pp. 93–100. DOI: 10.1007/s00535-012- 0610-3..
DOI: 10.1007/s00535-012- 0610-3

Коротяев А.И. Медицинская микробиология, иммунология и вирусология, СПб.: СпецЛит, 2002. [Korotyaev A.I. Medical Microbiology, immunology and Virology. Saint-Petersburg: Spetslit, 2002 (In Russ.)].

Манина В.В., Старшинова А.А., Пантелеев А.М. Туберкулез и ВИЧ-инфекция: эпидемическая ситуация в России и в мире за последние десять лет, особенности выявления и диагностики // ВИЧ-инфекция и иммуносупрессии. 2017. Т. 9, № 4. С. 7–16. [Manina V.V., Starshinova A.A., Panteleev A.M. Tuberculosis and HIV infection: epidemiological situation in Russia and in the world over the last ten years, particularly for detection and diagnosis. HIV Infection and Immunosuppressive Disorders, 2017, Vol. 9, No. 4, pp. 7–16 (In Russ.)].

Туберкулез и ВИЧ-инфекция: ведение больных с коинфекцией / Клинический протокол для Европейского региона ВОЗ (обновленная версия, 2013). Копенгаген, 2013. 52 с. [Tuberculosis HIV: management of patients with coinfection: Clinical Protocol for the Who European region (updated version, 2013). Copenhagen, 2013, 52 p.

Global tuberculosis report. Geneva: WHO, 2017.

Зимина В.Н., Кошечкин В.А., Кравченко А.В. Туберкулез и ВИЧ-инфекция у взрослых: руководство. М: ГЭОТАР-Медиа, 2014. 222 с. [Zimina V.N., Koshechkin V.A., Kravchenko A.V. Tuberculosis and HIV infection in adults: a guide. Moscow: GEOTAR-Media, 2014, 222 p. (In Russ.)].

Быхалов Л.С., Седова Н.Н., Деларю В.В., Богомолова Н.В., Голуб Б.В., Губанова Е.И., Гуров Д.Ю., Даниленко В.И., Замараев В.С., Кашина Н.П., Маланин Д.А., Матвеев О.В., Маслова Е.А., Самусев Р.П., Хлопонин П.А. Причины смерти и патоморфологическая характеристика органов при туберкулезе, ассоциированном с ВИЧ-инфекцией // Вестник ВолГМУ. 2013. № 3 (47). С. 64– 68. [Bykhalov L.S., Sedova N.N., Delarue V.V., Bogomolova N.V., Golub B.V., Gubanova E.I., Gurov D.Yu., Danilenko V.I., Zamaraev V.S., Kashina N.P. Malanin D.A., Matveev O.V., Maslova E.A., Samusev R.P., Khloponin P.A. Causes of death and pathological characteristics of organs in tuberculosis associated with HIV infection. Bulletin VolGMU, 2013, No. 3 (47), pp. 64–68 (In Russ.)].

Цинзерлинг В.А. ВИЧ-инфекция и туберкулез. Проблемы клинико-морфологических совпадений // Медицинский академический журнал. 2013. Т. 13, № 4. С. 87–91. [Zinserling V.A. HIV infection and tuberculosis. Problems of clinical and morphological matches. Medical Academic Journal, 2013, Vol. 13, № 4, pp. 87–91 (In Russ.)].